The infection drives PD-L1 expression in hepatocytes [1]. Also, HBV-specific T-cells are enriched in the liver, so it makes sense to target the PD-1/PD-L1 axis as this should help restore T-cell function [2].
However, I don't think this will be enough and combinations are needed [3,4].